You have 9 free searches left this month | for more free features.

Single Brain Metastasis

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer Trial in Messina, Rome, Turin (Silibinin, Placebo)

Recruiting
  • Brain Metastases, Adult
  • +2 more
  • Silibinin
  • Placebo
  • Messina, Italy
  • +4 more
Jan 9, 2023

NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic

Not yet recruiting
  • NSCLC
  • +5 more
  • single fraction stereotactic radiosurgery (SSRS)
  • fractionated stereotactic radiosurgery (FSRS)
  • (no location specified)
Jan 18, 2023

Brain Metastases Trial in Seoul (BT-M01)

Recruiting
  • Brain Metastases
  • BT-M01
  • Seoul, Song-pa Gu, Korea, Republic of
    Asan Medical Center
Oct 6, 2022

Breast Cancer With Brain Metastases Trial in Wuhan (pyrotinib+capecitabine+bevacizumab)

Recruiting
  • Breast Cancer With Brain Metastases
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 22, 2023

NSCLC Stage II, Bevacizumab, Immunotherapy Trial in Guangzhou (Serplulimab combined with bevacizumab and first-line chemo)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage II
  • +3 more
  • Serplulimab combined with bevacizumab and first-line chemotherapy
  • Guangzhou, Guangdong, China
    Likun Chen
Apr 10, 2023

Furmonertinib, EGFR-mutation, NSCLC Trial in Beijing (Furmonertinib)

Recruiting
  • Furmonertinib
  • +3 more
  • Beijing, China
    Ethics Committee
Jul 15, 2022

Brain Metastases, Adult Trial in Durham (Stereotactic radiosurgery)

Completed
  • Brain Metastases, Adult
  • Stereotactic radiosurgery
  • Durham, North Carolina
    Duke University Medical Center
May 9, 2022

Breast Cancer Trial in Zhengzhou (utidelone, Bevacizumab)

Recruiting
  • Breast Cancer
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Sep 15, 2022

Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)

Recruiting
  • Metastatic HER2 Negative Breast Carcinoma
  • +3 more
  • UTD1 combined with capecitabine
  • Changsha, China
    Quchang Ouyang
Sep 9, 2022

Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Patritumab deruxtecan
  • (no location specified)
May 9, 2023

Brain Metastases Trial in Changsha (ASCLU-300 TTF)

Recruiting
  • Brain Metastases
  • ASCLU-300 TTF
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Feb 27, 2022

Tumor Metastasis, CNS Metastases Trial in Albuquerque (Intensity Modulated Radiotherapy)

Completed
  • Neoplasm Metastasis
  • Central Nervous System Metastases
  • Intensity Modulated Radiotherapy
  • Albuquerque, New Mexico
    Universtiy of New Mexico Comprehensive Cancer Center
Apr 21, 2022

Malignant Tumors, Brain Lymphoma, CNS Lymphoma Trial in Seoul (Usefulness of Gadovist-enhanced FLAIR imaging in differentiation

Completed
  • Malignant Tumors
  • +2 more
  • Usefulness of Gadovist-enhanced FLAIR imaging in differentiation between a glioblastoma and solitary brain metastasis
  • Seoul, Gurogu, Korea, Republic of
    Korea University Guro Hospital
Mar 14, 2022

Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid

Recruiting
  • Lung Cancer
  • +5 more
  • Stereotactic Radiosurgery
  • Cerebrospinal fluid collection
  • Basking Ridge, New Jersey
  • +6 more
Nov 11, 2022

Malignant Tumors of Eye Brain and Other Parts of CNS Trial in Houston (Spine Radiosurgery, Questionnaires)

Recruiting
  • Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
  • Spine Radiosurgery
  • Questionnaires
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Brain Metastases, Posterior Fossa Lesion, Cerebral Lesion Trial in Jerusalem (Radiation treatment)

Recruiting
  • Brain Metastases
  • +2 more
  • Radiation treatment
  • Jerusalem, Israel
    Hadassah Ein Kerem Medical Center
Jul 25, 2022

Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)

Withdrawn
  • Breast Cancer
  • +3 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 28, 2022

Brain Metastasis, Oligoprogression Trial in France (Hypofractionated SRT (stereotactic radiotherapy), Historical single-dose SRS

Active, not recruiting
  • Brain Metastasis
  • Oligoprogression
  • Hypofractionated SRT (stereotactic radiotherapy)
  • Historical single-dose SRS (stereotactic radiosurgery)
  • Bordeaux, France
  • +12 more
Aug 9, 2022

Cerebral Metastases of Solid Cancers Trial in Erlangen (Radiosurgery, Fractionated stereotactic radiotherapy)

Recruiting
  • Cerebral Metastases of Solid Cancers
  • Radiosurgery
  • Fractionated stereotactic radiotherapy
  • Stuttgart, Baden-Württemberg, Germany
  • +12 more
Dec 9, 2022

Brain Metastases, Resection Cavity Trial in Munich (Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction

Recruiting
  • Brain Metastases
  • Resection Cavity
  • Hypofractionated stereotactic radiotherapy (HFSRT) versus single fraction stereotactic radiotherapy radiosurgery (SRS)
  • Munich, Bavaria, Germany
    Dept. Radiation Oncology
Dec 6, 2021

Melanoma, Brain Metastases Trial in Spain (Ipilimumab)

Completed
  • Melanoma
  • Brain Metastases
  • Badalona, Spain
  • +11 more
Oct 10, 2022

Brain Metastases, Breast Cancer, Metastatic Breast Cancer Trial in Multiple Locations (BKM120, capecitabine, Trastuzumab)

Completed
  • Brain Metastases
  • +2 more
  • Multiple Locations, Texas
    Please contact Zuzanne Bristow for list of sites
Jan 31, 2022

Brain Metastases, Adult, Cancer Brain Trial in Switzerland (IGRT, SRS)

Recruiting
  • Brain Metastases, Adult
  • Cancer Brain
  • IGRT
  • SRS
  • Bellinzona, Ticino, Switzerland
  • +5 more
Feb 9, 2022

Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)

Not yet recruiting
  • Brain Metastases
  • +2 more
  • 18F fluciclovine
  • Miami, Florida
    Miami Cancer Institute
Sep 15, 2023

NSCLC Stage IV, Brain Metastases, Immunotherapy Trial in Hangzhou (Immunotherapy, WBRT, Chemotherapy)

Recruiting
  • NSCLC Stage IV
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Sep 3, 2021